Explore the groundbreaking research on psychedelic drugs and their potential to revolutionize mental health treatment in this 32-minute World Economic Forum talk from Davos 2019. Delve into the science behind psychedelics as Robin Carhart-Harris, Head of the Centre for Psychedelic Research at the University of Oxford, discusses their effects on brain networks, mental illness, and long-lasting therapeutic outcomes. Learn about the research process, the differences between psychedelics and current antidepressants, and the concept of ego disintegration. Discover the potential of these substances in treating addictions and fostering spiritual experiences. Address common misconceptions, safety concerns, and the path towards mainstream acceptance of psychedelic-assisted therapies. Gain insights into guided sessions and the phenomenon of microdosing as Carhart-Harris is interviewed by Alyson Shontell Lombardi, Editor-in-Chief of Business Insider US.